Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.


Contact Us >>

WhatsApp  +86 18163351462(WhatsApp)
Paper Publishing WeChat
Book Publishing WeChat
(or Email:book@scirp.org)

Article citations


Ntagirabiri, R., Munezero, B., Kaze, H., Ndirahisha, E. and Manirakiza, S. (2015) Incidence du carcinome hépatocellulaire lors de l’infection chronique par le virus de l’hépatite B. Pan African Medical Journal, 20.

has been cited by the following article:

  • TITLE: Evaluation of Viral Hepatitis B Treatment in Pointe-Noire in 2016

    AUTHORS: F. Bossali, G. Ndziessi, C. L. Ahoui-Apendi, G. Deby, M. J. F. Mimiesse, J. W. Ombila, B. I. Atipo-Ibara, J. R. Ibara

    KEYWORDS: Access, Congo, Hepatitis B, Pointe-Noire, Treatment

    JOURNAL NAME: International Journal of Clinical Medicine, Vol.9 No.6, June 13, 2018

    ABSTRACT: Prevalence of hepatitis B in Pointe-Noire is 23%. The objective of this study was to evaluate the level of therapeutic management of patients with hepatitis B in Pointe-Noire. Methods: A retrospective, cross-sectional, descriptive and analytical study. Results: 302 patients included: 217 (72%) men and 85 (28%) women of median age 40 years. The viral load was measured in 140 (46%) patients and in 162 (54%), the viral load was not measured. Their distribution according to the viremia was as follows: 0 - 1 log = 1 (0.7%) patients; 1.5 to 2 log = 23 (16%) patients; 2.5 to 3 log = 49 (35%) patients; >3log = 55 (39%) patients. Of the 302 patients included, 36 (11%) patients were treated with antivirals and 253 (83%) patients were not. Conclusion: The number of patients treated for chronic viral hepatitis B was low. Our results show interest for improved preventive and curative management of hepatitis B in Congo in order to reduce the existing high prevalence.